Polaroid Therapeutics
Switzerland - SchlierenBiotechnology
Focus: Polaroid Therapeutics is a Swiss-based biotechnology company founded in 2022 focused on antimicrobial coatings and therapies for infectious diseases. The company operates as a pre-revenue stage biotech with a specialized focus on a narrow but potentially high-impact therapeutic area.
Profile data last refreshed 3h ago · AI intelligence enriched 2mo ago
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Polaroid Therapeutics?
AI assessmentPolaroid Therapeutics represents a high-risk, high-upside early-stage opportunity best suited for mission-driven scientists willing to weather pre-clinical uncertainty in exchange for foundational company-building experience.
Why Work Here
- Early-stage entry point at a company addressing the critical unmet need of antimicrobial resistance, a WHO-designated priority health threat
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (1)
Interview Prep Quick Facts
Help build intelligence for Polaroid Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.